View Article

  • Herbal Approaches in the Treatment of Myocardial Infarction : A Phytochemical Perspective

  • Department of Pharmacy, LCIT School of Pharmacy, Bilaspur

Abstract

Myocardial infarction (MI) is one of the most common and serious heart conditions, caused mainly by a sudden fallor blockage in the blood flow to the heart muscle. This interruption leads to a lack of oxygen, which triggers inflammation, oxidative stress, and gradual damage or death of cardiac cells. Even though modern medicines such as antiplatelet drugs, beta-blockers, statins, and ACE inhibitors are widely used, many patients continue to face side effects, high costs, or limited improvement in long-term heart recovery. These challenges have encouraged interest in natural remedies, especially medicinal plants, which have been used for generations in traditional healing systems. Several medicinal plants-such as Terminalia arjuna, Withania somnifera, Moringa oleifera, Magnolia officinalis, Allium sativum, Panax ginseng, and Ocimum sanctum—contain beneficial compounds that help protect the heart. These plants are rich in antioxidants and other natural chemicals that reduce inflammation, lower cholesterol, improve blood circulation, and protect the heart muscle from further injury. Many experimental studies have shown that these herbs can reduce the size of the affected area after an infarction, support stronger heart function, and prevent oxidative damage. Although most evidence currently comes from laboratory or animal studies, the results are encouraging and point toward real therapeutic potential. Overall, medicinal plants offer a promising and safer approach to supporting heart health,especially in the prevention and management of myocardial infarction. Their natural origin, affordability, and broad biological actions make them valuable alternatives or supplements to standard treatments. However, more well-designed human studies are needed to confirm their effectiveness, determine proper dosages, and ensure safety.

Keywords

Myocardial Infarction, Medicinal Plants, Heart Protection, Oxidative Stress, Natural Remedies, Terminalia arjuna, Allium sativum, Moringa oleifera

Introduction

MI happens when coronary blood supply to a part of the myocardium is suddenly reduced or stopped, resulting in ischaemia and eventual cardiac tissue destruction. Although additional etiologies such coronary spasm, embolism, or dissection may also be implicated, the most frequent underlying mechanism is the rupture or erosion of an atherosclerotic plaque followed by thrombus development[1]. Insufficient blood flow to the coronary arteries causes myocardial infarction (MI), which is typically brought on by coronary artery stenosis or blockage . 10.636.5 million cases of MI brought on by ischaemic heart disease occurred worldwide in 2017[2]. According to the World Health Organization, MI significantly affects people's lives and is currently the world's leading cause of mortality. As a result, prevention and treatment of MI have gained significant attention[3].

The burden of MI is still rising globally due to ageing populations and rising rates of risk factors as smoking, obesity, diabetes mellitus, dyslipidaemia, and hypertension. According to contemporary epidemiological data, MI makes up a sizable component of cardiovascular diseases, which cause almost one-third of all deaths[4]. Prompt diagnosis and timely reperfusion therapy, either mechanically or pharmacologically, are crucial for reducing myocardial damage and enhancing therapeutic results. Medication, such as aspirin, nitroglycerin, beta-blockers, diuretics, statins, angiotensin-converting enzyme inhibitors.

(ACEI)/ angiotensin receptor blockers (ARB), and aspirin, is one of the most basic methods of treating MI [5]. The most effective and popular treatments for MI at the moment are percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG), which aim to increase the blood supply to the ischaemic myocardium[6].

The hallmark of MI is the death of heart cells due to a reduced oxygen supply caused by a blocked coronary artery. Variations in intracellular O2 levels have a major effect on oxidative metabolism, which is the main source of cardiac energy generation. Because coronary artery blockage reduces oxygen levels and increases anaerobic-dependent ATP synthesis, it results in energy starvation and cardiac cell necrosis[7].

Pharmacological therapies for MI have actually advanced from basic diuretics and vasodilators to combinations of diuretics, blockers and angiotensin-converting enzyme inhibitors[8]. These medications are crucial for reducing symptoms, boosting myocardial oxygen consumption, and improving haemodynamic parameters, but they don't deal with the underlying causes of MI or its after effects[9]. Traditional medicine has a long history and widespread use in this field globally, and plants offer a multitude of resources for anti-MI medications. Notably, natural product therapies are widely acknowledged as additional or alternative treatments for MI[10]. The use of botanical metabolites in these treatments has gained a lot of attention since they are typically kinder and safer than chemically produced anti-MI metabolites [11]. Medicinal plants have been utilised for ages  to prevent, treat, or cure illnesses because they contain chemical compounds with therapeutic qualities[12]. They still have a big impact on both conventional and contemporary healthcare systems, and they serve as the foundation for many contemporary drugs. The goal of this article is to provide a thorough analysis of natural remedies and medicinal herbs used in the last five years to prevent and cure MI[13]. Based on MI's pathogenesis and treatment strategies. Apart from providing an innovative perspective to enhance research and discover new herbs for MI treatment, this study aims to establish a knowledge base for future studies on natural  products and medicinal plants in MI treatment[14].

Important medicinal plants and their phytochemistry:

  1. Terminalia arjuna:-

T. arjuna is an important Ayurvedic medicinal plant. It belongs to the Combretaceae family, which hasover 200 species worldwide, and is frequently referred to as Arjuna, Indradru, Partha, and Veeravriksha[15]. Almost 24 species of Terminalia have been identified from various regions of India, including Terminalia bellirica, Terminalia bialata, Terminalia catappa, Terminalia elliptica, Terminalia porphyrocarpa, Terminalia mantaly, and T. arjuna[16]. India, Burma, Mauritius, and Sri Lanka are home to arjuna. It features drooping branches, acrown that spreads horizontally, and a buttressed trunk. Its height ranges from 60 to 80 feet[17]. In the sub-Indo-Himalayan areas of Uttar Pradesh, Punjab, Deccan, South Bihar, Orissa, West Bengal, and Madhya Pradesh, T. arjuna is primarily found around rivers, rivulets, and ponds[18].

Fig1:-Terminalia arjuna

Phytochemistry:- The therapeutic tree Terminalia arjuna (Family: Combretaceae) is well-known for its cardioprotective qualities. The plant's pharmacological effects are influenced  by a variety of bioactive substances found in its bark, leaves, fruits, and seeds, including triterpenoids, flavonoids, glycosides, tannins, and minerals[19].

Table1:- Summary of phytochemicals present in Terminalia arjuna by plant parts

Sr. No.

Plant parts

Major phytochemicals

Pharmacological significance

1.

Bark

Arjunic acid, Arjunolic acid, Arjunosides, Tannins, Flavonoids

Cardioprotective, Antioxidants, Anti- inflammatory.

2.

Leaves

Flavonoids, Tannins, Saponins

Antioxidants, Antimicrobial.

3.

Fruits

Gallic acid, Ellagic acid, β-sitosterol

Lipid–lowering, Hepatoprotective.

4.

Seeds

Phytosterols, polyphenols

Cholesterol-lowering, Antioxidants.

5.

Roots

Triterpenoids, Glycosides

Suppourtive Cardioprotective role.

  1. Withania somnifera:-

Withania somnifera Dunal, which is a member of the Solanaceae family. This shrub grows throughout the Mediterranean, the Canaries, the Cape of Good Hope, and the drier sections of India, Sri Lanka, Afghanistan, Baluchistan, Sind, and portions of Africa. In the Himalayas, it can be found at elevations of up to 5,500 feet[20]. It grows widely all over India, especially in hotter regions, on waste sites, and at the sides of roads. In India, it is also grown for medical purposes. It is extensively grown in the Garhwal Hills, Rajasthan village, and Mandsaur, Madhya Pradesh. The tomentose shrub Withania somnifera is upright, branching, and evergreen (green all year round). Simple, petiolate leaves range in size from 4 to 10 cm in length and 2 to 7 cm in width. The leaf blades are whole along the edges, acute to obtuse at the apex, oblique at the base, and covered with a persistent greyish tomentum on the sides[21].

Fig 3 :-Withania somnifera

Phytochemistry :- Withania somnifera, which is also referred to as Indian ginseng or ashwagandha, is a well-known adaptogenic and cardioprotective medicinal herb. Myocardial infarction (MI) can be prevented and treated with the help of its bioactive compounds, which have anti-inflammatory, anti-apoptotic, antioxidant, and hypolipidemic qualities[22].

Table2:-Summary of phytochemicals present in withania somnifera by plant parts

Sr. No.

Plant parts

Major phytoconstituents

Pharmacological significance

1.

Bark

Phenolics, Withanolides

Mild antioxidants.

2.

Leaves

Withaferin-A, Flavonoids

Antioxidants, Anti– apoptotic.

3.

Fruits

Withanolides, Fatty acids

Lipid metabolism regulation.

4.

Seeds

Amino acids, Alkaloids

Nutritional support.

5.

Roots

Withanolides , Alkaloids, Sitoindosides

Antioxidants, Anti-inflammatory, Hypolipidemic.

  1. Magnolia officinalis:-

The deciduous medicinal tree Magnolia officinalis is indigenous to China's mountain forests and a member of the Magnoliaceae family. Its large, dark green leaves and fragrant white flowers bloom in the summer, and it can reach a height of 20 to 30 feet[23]. The primary portion used for medicinal purposes is the thick, fragrant bark. It has long been used in Chinese medicine under the name Houpu to treat circulation issues, anxiety, and digestive issues. The bark's pharmacological qualities, which include cardioprotective, anti-inflammatory, and antioxidant actions, are attributed to bioactive compounds including honokiol and magnolol[24]. Recent studies have shown that honokiol activates the PI3K/AKT signalling pathway, which has cardioprotective effects in myocardial ischaemia and reperfusion injury, while reducing oxidative stress, inflammation, and cardiomyocyte apoptosis. Both heart function and the size of infarcts are improved by these actions[25].

Fig 5:-Magnolia officinalis

Phytochemistry:- The plant's bioactive lignans, alkaloids, terpenoids, and phenolic compounds are mostly found in the bark of Magnolia officinalis, while they can also be found in the leaves, roots, and seeds. Its numerous pharmacological properties, such as antimicrobial, anti-inflammatory, antioxidant, and cardioprotective effects, are attributed to these phytochemicals[26].

Table3:- Summary of phytochemicals present in Magnolia officinalis by plant parts

Sr. no.

Plant parts

Major phytoconstituents

Pharmacological significance

1.

Bark

Honokiol, Magnolol, Obovatol, Magnoflorine, Costunolide, β-Eudesmol

Antioxidants, Anti-inflammatory, Anti-anxiety, Cardioprotective.

2.

Leaves

Magnolignan, Eudesmol, Linalool, α Pinene, β-Caryophyllene

Antibacterial, Anti-inflammatory, Calming and relaxing effects.

3.

Roots

Magnoflorine, Honokiol, Magnolol

Sedative, Anti–inflammatory, Antioxidants.

4.

Seeds

Honokiol, Magnolol, Fatty acid, phenolic compounds

Antioxidants, Antimicrobial.

5.

Flowers

Linalool, Eudesmol, Magnolol (trace)

Fragrance, Antioxidants, Mild antimicrobial.

  1. Moringa Oleifera:-

One of the most extensively grown species of  the Moringaceae family is the significant medical plant Moringa oleifera. Since ancient times, it has been highly prized due to its numerous therapeutic benefits. The wild tree grows in the Sub-Himalayan areas between Chenab and Oudh. It can grow as high as 1400 meters above the sea level[27]. People often grow it near their homes in Assam, Bengal and the Indian peninsula. It's an excellent coppicer. Additionally, it is grown in the northeastern regions of Bangladesh, Pakistan, Sri Lanka, West Asia, the Arabian Peninsula, East and West Africa, the West Indies, southern Florida, and Central and South America, ranging from Mexico to Peru, Brazil, and Paraguay[28]. Moringa oleifera is a small, fast-growing evergreen or deciduous tree that usually reaches a height of nine meters. It has soft, white wood and corky, sticky bark. Horse radish is the flavor of the roots.The leaves have glabrous, entire leaflets, jointed branches that are glandular at the joints, longitudinal fissures, and a main axis that is 30 to 75 cm long. The leaflets have a small tip at the base, a rounded  or blunt-pointed apex, entire (not toothed) borders, and red-tinged mid-veins[29].

Fig 7:-Moringa oliefera

Phytochemistry:- Moringa oleifera, also known as the drumstick tree or horse radish tree, is a very important medicinal plant that is full of bioactive compounds that are good for the heart. Flavonoids, phenolic acids, alkaloids, glucosinolates, and terpenoids.

The phytochemicals that can be found in the leaves, seeds, pods, flowers, and roots of the plant[30].

Table4:- Summary of phytochemicals present in moringa oliefera by plant parts

Sr. no.

Plant parts

Major phytoconstituents

Pharmacological significance

1.

Leaves

Quercetin, Kaempferol, Chlorogenic acid, β-sitosterol, Ascorbic acid

Potent antioxidants and anti – inflammatory, reduce lipid peroxidation and myocardial

Oxidative stress.

2.

Seeds

Oleic acid, Palmitic acid, Sterols, Flavonoids

Hypolipidemic and membrane stabilizing effects, protect cardiac cells from injury.

3.

Pods

Vitamin–C, Carotenoids, Polyphenols

Enhance antioxidants defense and protect cardiac tissues from oxidative stress.

4.

Flowers

Phenolic acid, Flavonoids, Alkaloids

Anti–inflammatory and free radical scavenging properties, improve

endothelial functions.

5.

Roots

Moringine (benzylamine alkaloids), Tannins, Saponins

Vasodilatory and cardioprotective effects, improve coronary circulation and reduce cardiac load.

  1. Allium sativum :-

Garlic, or Allium sativum, was one of the first plants to be grown. It has been used as a spice, food, and traditional medicine for over 4,000 years. It is the medicinal plant that has been researched the most (Milner 1996)[31]. In 22 therapeutic formulations found in the Egyptian medical papyrus Codex Ebers, which dates to around 1550 B.C., garlic is mentioned as a helpful treatment for a number of diseases, including tumours, worms, headaches, heart tissues, and bites [32]. Bulbs are rounded and made up of up to fifteen tiny clove-like bulblets. A white or pinkish tunic (papery garment) covers the cloves and bulbs. An subterranean stem is connected to four to twelve long, sword-shaped leaves. Spherical cluster up to 25 cm long on a spike (flower stalk). The six perianth segments (petals and sepals) of greenish white or pinkish flowers are roughly 3 mm long[33].

Fig9:-Allium sativum

Phytochemistry:- Allium sativum, is dominated by organo sulfur compounds, which are primarily found in the bulb (clove) and include alliin, allicin, ajoene, diallyl disulphide (DADS), diallyl trisulfide (DATS), and S-allyl-L-cysteine (SAC). While garlic oil is abundant in volatile sulphides (DADS, DATS), aged garlic extract contains stable water-soluble compounds like SAC. All of which support its cardioprotective and antioxidant properties. By lowering oxidative stress, inflammation, platelet aggregation, and myocardial cell damage, these components work together to protect against myocardial infarction (MI)[34].

Table 5:- Summary of phytochemicals present in allium sativum by plant parts

Sr. No.

Plant parts

Major phytoconstituents

Pharmacological significance

1.

Bulb (fresh)

Alliin, Allicin, DADS, DATS, Ajoene

Antioxidants, Vasodilatory, Antithrombotic.

2.

Aged garlic  extract

S-allyl-L-cysteine, S–allyl mercaptocysteine

Anti-apoptotic, Antioxidants, Cardioprotective.

3.

Garlic oil

DADS, DATS, Ajoene

Prevents platelets aggregation, enhances NO release.

4.

Leaves and peel

Flavonoids, Phenolics, Saponins

Antioxidants, Anti– inflammatory.

  1. Panax ginseng

Panax ginseng was first grown in 11 BC and has been used medicinally for over 5,000 years. The genus name "Panax," which comes from the Greek words "pan," which means all, and "axos," which means medicine, was given to Panax ginseng by the Russian scientist C.A. Meyer[35]. The commercially available ginseng roots are divided into two categories based on how they are processed: red ginseng (RG) and white ginseng (WG). One possible explanation for the variations in the biological activity of WG and RG is that their industrial processing alters their chemical composition[36]. The common names for the genus Panax and the family Araliaceae are "Ginseng" and "Ginseng Family," respectively, according to Gray's Manual of Botany. In this instance, the common names of a genus and a family of plants that bloom[37].

Fig 11:-Panax ginseng

Phytochemistry:- The popular medicinal plant Panax ginseng, also known as Korean ginseng, is prized for its adaptogenic and cardioprotective qualities. Its high concentration of bioactive ginsenosides, polysaccharides, polyacetylenes, peptides, and phenolic compounds are largely responsible for its therapeutic action against myocardial infarction (MI)[38].

Table6:- Summary of phytochemicals present in panax ginseng by plant parts

Sr. no.

Plant parts

Major phytoconstituents

Pharmacological significance

1.

Roots

Ginsenosides (Rb1, Rg1, Rg3, Rd, Re, Rh1, Rh2), polysaccharide

Antioxidants, Anti– inflammatory, Anti-apoptotic, improve Cardiac function and reduce infract size.

2.

Leaves and stems

Ginsenosides (Rg1, Rd, Re), Polyecetylenes, Flavonoids

Enhance coronary blood flow, reduce oxidative stress, protect cardiomyocytes.

3.

Barriers (fruits)

Ginsenoside Re, Polysaccharides, phenolic acids

Reduce lipid peroxidation, improve cardiac metabolism and antioxidant defense

  1. Ocimum sanctum :-

Ocimum sanctum has been acknowledged as one of the most versatile therapeutic herbs with a wide range of biological activity for more than 2000 years. On the Indian subcontinent, this widely utilised religious herb is called holy basil or tulsi. Basils, which most likely originated in India, are found across tropical Asia[39]. Usually cultivated from seeds, it is an annual plant. It is extensively distributed in tropical climates and may be found at an elevation of 1800 meters in the Himalayan region. In many parts of Asia and Africa, certain tulsi variants grow well in the wild[40]. Leaves are dark brown on the outside and on the inside it is a delicated shade of violet with hairy and subgrandular flowers that are dark purple to black on the outside and cream on the outside. The flower's pedicels are longer than the calyx, which is ovoid or campanulate and 3–4 mm bilipped; the lower lips, which are 170 times longer than the upper, have four mucronate teeth, the two largest in the centre; the upper lips are broadly rectangular or suborbicular[41].

Fig 13 :-Ocimum sanctum

Phytochemsitry :- Ocimum sanctum, sometimes referred to as holy basil or tulsi, has strong antioxidant and cardioprotective qualities that are helpful in the treatment of myocardial infarction (MI). Its rich phytochemical composition, which improves endogenous antioxidant defences and lowers oxidative stress, lipid peroxidation, and myocardial necrosis, is largely responsible for its therapeutic potential. Numerous bioactive components, including flavonoids, phenolic acids, terpenoids, and essential oils, are found in various parts of Ocimum sanctum and are essential for cardio-protection[42].

Table7:-Summary of phytochemicals present in Ocimum sanctum by plant parts

Sr. no.

Plant parts

Major phytoconstituents

Pharmacological significance

1.

Leaves

Eugenol, Ursolic acid, Apigenin, Luteolin, Rosmarinic acid, Orientin, Vicenin, Carvacol

Antioxidants, Anti – inflammatory, Anti – apoptotic effects and reduce lipid peroxidation and protect cardiac tissue from ischemic injury.

2.

Seeds

Linoleic acid, Oleic acid and fixed oils

Regulate lipid metabolism, improve membrane stability and exhibit hypolipidemic effects.

3.

Roots

Triterpenoids, Saponins and phenolic compounds

Improve myocardial

Antioxidants defence and reduce infract size.

4.

Stem

Phenolic acid, Flavonoids and Tannins

Contribute to vascular protection and inhibition of inflammatory mediators.

5.

Essential oil (whole plant )

Eugenol, Methyl eugenol, Caryophyllene and Linalool

Vasodilatory, Antiplatelet and free-radical scavenging effects and improving coronary bloodflow.

Mechanism of Medicinal Plants in Treatment of MI

Medicinal plants play an important supportive role in the management of myocardial infarction by protecting heart muscle cells, improving blood flow, and reducing damage caused by oxidative stress and inflammation.

Table8 :-Mechanism of various medicinal plants in treatment of MI

Sr. No.

Medicinal Plant

Major Active Constituents

Key Mechanism in Myocardial Infarction

1

Terminalia arjuna

Arjunic acid, Arjunolic acid, Arjunosides, Tannins, Flavonoids

Enhances myocardial contractility, reduces oxidative stress, stabilizes cardiac cell membrane, improves coronary blood flow, prevents lipid accumulation in coronary arteries

2

Withania somnifera

Phenolics, Withanolides, Withaferin-A, Flavonoids

Protects cardiomyocytes by reducing oxidative stress and inflammation, regulates stress hormones, limits ischemia-induced cell death, supports myocardial recovery

3

Magnolia officinalis

Honokiol, Magnolol, Obovatol, Magnoflorine, Costunolide, β-Eudesmol

Suppresses inflammatory signaling, reduces oxidative damage, prevents calcium overload in cardiac cells, protects myocardial tissue during ischemic injury

4

Moringa oleifera

Quercetin, Kaempferol, Chlorogenic acid, β-sitosterol, Flavonoids

Scavenges free radicals, reduces lipid peroxidation, protects heart tissue from ischemia-related oxidative injury

5

Allium sativum

Alliin, Allicin, DADS, DATS, Ajoene, S-allyl-L-cysteine

Inhibits platelet aggregation, lowers cholesterol, improves endothelial function, enhances nitric oxide (NO) availability

6

Panax ginseng

Ginsenosides (Rb1, Rg1, Rg3, Rd, Re, Rh1, Rh2), Polysaccharides, Phenolic acids

Improves mitochondrial energy metabolism, reduces oxidative stress, modulates inflammatory pathways, enhances survival of cardiac cells after infarction

7

Ocimum sanctum

Eugenol, Ursolic acid, Apigenin, Luteolin, Rosmarinic acid, Orientin, Vicenin, Carvacrol

Reduces oxidative stress, suppresses inflammatory mediators, enhances endogenous antioxidant enzymes, limits myocardial cell injury during infarction

CONCLUSION

Myocardial infarction (MI) is still the number one cause of death around the world. It happens because of oxidative stress, inflammation, and damage to cells. The drawbacks of existing synthetic drugs, including adverse effects and exorbitant costs, underscore the necessity  for safer and more efficacious alternatives. Medicinal plants present a promising a venue owing to their extensive variety of bioactive phytoconstituents possessing antioxidant, anti-inflammatory, anti-apoptotic, and cardioprotective attributes. Plants including Terminalia arjuna, Withania somnifera, Allium sativum, Moringa oleifera, Panax ginseng, Magnolia officinalis, and Ocimum sanctum have shown substantial potential in preventing and controlling MI by altering critical molecular pathways involved in heart damage. Novel plant-based cardioprotective treatments may be made possible by fusing traditional herbal knowledge with contemporary pharmacological and clinical research. Medicinal plants have the potential to improve cardiovascular health worldwide by acting as safe, economical, and sustainable substitutes or supplements to  traditional MI treatments with more scientific validation, standardization, and clinical studies.

The advancement of translational research and scientific validation will determine the future of treating myocardial infarction (MI) with medicinal plants. Using contemporary pharmacological, genomic, and bioinformatics tools to standardize herbal extracts, identify bioactive phytoconstituents, and determine their specific molecular processes is becoming increasingly important. Carefully considered clinical trials should come after preclinical research to verify safety, effectiveness, and dosage optimization in humans. Additionally, the development of sophisticated formulations such as liposomes, phyto-complexes, and nanoparticles can greatly enhance the stability, bioavailability, and targeted transport of compounds obtained from plants to cardiac tissues. Finding novel cardioprotective medications with fewer side effects will be made simpler by fusing traditional medical knowledge with contemporary drug development technologies.

REFERENCES

  1. Zhang MX, Song Y, Xu WL, Zhang LX, Li C, Li YL. Natural herbal medicine as a treatment strategy for myocardial infarction through the regulation of angiogenesis. Evidence-Based Complementary and Alternative Medicine. 2022;2022(1):8831750
  2. Fathima SN. An update on myocardial infarction. Current Research and Trends in Medical Science and Technology. 2021;1:95.
  3. Oliveira GB, Avezum A, Roever L. Cardiovascular disease burden: evolving knowledge of risk factors in myocardial infarction and stroke through population-based research and perspectives in global prevention. Frontiers in cardiovascular medicine. 2015 Aug 13;2:32.
  4. Satish S, Aravind BC. Advancements In Pharmacotherapy for Myocardial Infarction: A Comprehensive Review.
  5. Frangogiannis NG. Pathophysiology of myocardial infarction. Comprehensive Physiology. 2015 Oct 17;5(4):1841-75
  6. Tibaut M, Mekis D, Petrovic D. Pathophysiology of myocardial infarction and acute management strategies. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Cardiovascular & Hematological Agents). 2016 Dec 1;14(3):150-9.
  7. Rosendorff C, Lackland D T, Allison M, Aronow W S, Black H R, Blumenthal R S, Cannon CP, De Lemos JA, Elliott WJ, Findeiss L, Gersh BJ. Treatment of hypertension inpatients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Journal of the American College of Cardiology. 2015 May 12;65(18):1998-2038.
  8. Hart BL. The evolution of herbal medicine: behavioural perspectives. Animal Behaviour. 2005 Nov 1;70(5):975-89.
  9. Shaito A, Thuan DT, Phu HT, Nguyen TH, Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH, Pintus G. Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety. Frontiers in pharmacology. 2020 Apr 7;11:422.
  10. Nisar A, Jagtap S, Vyavahare S, Deshpande M, Harsulkar A, Ranjekar P, Prakash O. Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinicaltrials to clinicalpractice. Frontiers in pharmacology. 2023 May9;14:1177050.
  11. Demirsoy E, Thielmann M. Abstracts from the 72nd Congress of the ESCVS, the European Society of CardioVascular and Endovascular Surgery. InMedical Sciences Forum 2025 Apr 3 (Vol. 31, No. 1, p. 1). MDPI.
  12. Veveris M, Koch E, Chatterjee SS. Crataegus special extract WS® 1442 improvescardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sciences. 2004 Feb 27;74(15):1945-55.
  13. Jain S, Yadav PP, Gill V, Vasudeva N, Singla N. Terminalia arjuna a sacred medicinal plant: phytochemical and pharmacological profile. Phytochemistry Reviews. 2009 Jun;8(2):491-502.
  14. Elsawy H, Almalki M, Elmenshawy O, Abdel-Moneim A. In vivo evaluation of the protective effects of arjunolic acid against lipopolysaccharide-induced septic myocardial injury. PeerJ. 2022 Feb 16;10:e12986.
  15. Srimachai S, Devaux S, Demougeot C, Kumphune S, Ullrich ND, Niggli E, Ingkaninan K, Kamkaew N, Scholfield CN, Tapechum S, Chootip K. Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury. BMC complementary and alternative medicine. 2017 Feb 20;17(1):117.
  16. Nandave M, Ojha SK, Joshi S, Kumari S, Arya D S. Moringa oleifera leaf extract prevents isoproterenol-induced myocardial damage in rats: evidence for an antioxidant, antiperoxidative, and cardioprotective intervention. Journal of medicinal food. 2009 Feb 1;12(1):47-55.
  17. Nyepetsi NG. Effects of dietary garcinia kola supplementation on inflammation and oxidative stress in isolated perfused rat hearts.
  18. Suleiman KY, Ajani EO, Biobaku KT, Okediran BS, Azeez MO, Jimoh GA, Aremu A, Ahmed AO. Cardioprotective effects of aqueous extract of ripped musa paradisiaca peelin isoproterenol induced myocardial infarction rat model. Biomedical Research and Therapy. 2021 Oct 29;8(10):4634-48.
  19. G Narayanan GN, K Prabhu KP, Bandhu Chaudhury A. Cardioprotective role of partharishtam on isopreterenol induced myocardial infarction in animal model.
  20. Mohamed D, Mabrok H, Abdelgayed S, Elbakry H. Cardioprotective potency of anthocyanin-rich extract of red cabbage against isoproterenol-induced myocardial infarction in experimental animals. Journal of Applied Pharmaceutical Science. 2021 Jun 12;11(8):022-30.
  21. Garg SS, Gupta J, Sahu D, Liu CJ. Pharmacological and therapeutic applications of esculetin. International journal of molecular sciences. 2022 Oct 20;23(20):12643.
  22. Hammoudeh AJ, Alhaddad IA. Triggers and the onset of acute myocardial infarction. Cardiology in Review. 2009 Nov 1;17(6):270-4.
  23. M?ynarska E, Czarnik W, Fularski P, Hajdys J, Majchrowicz G, Stabrawa M, Rysz J, Franczyk B. From atherosclerotic plaque to myocardial infarction—The leading cause of coronary artery occlusion. International journal of molecular sciences. 2024 Jul 2;25(13):7295.
  24. Nayler WG. Atherosclerosis and endothelial damage: a brief overview. Cardiovascular drugs and therapy. 1995 Jan;9(Suppl 1):25-30.
  25. Tiwari BS, Belenghi B, Levine A. Oxidative stress increased respiration and generationof reactive oxygen species, resulting in ATP depletion, opening of mitochondrial permeability transition, and programmed cell death. Plant physiology. 2002 Apr 1;128(4):1271-81.
  26. Perrelli MG, Pagliaro P, Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World journal of cardiology. 2011 Jun 26;3(6):186.
  27. Turner NA. Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). Journal of molecular and cellular cardiology. 2016;94:189-200.
  28. Stožer A, Vodopivc P, Bombek L K. Pathophysiology of exercise-induced muscle damage and its structural, functional, metabolic, and clinical consequences. Physiological research. 2020 Jul 16;69(4):565.
  29. Amalraj A, Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: a review. Journal of traditional and complementary medicine. 2017 Jan 1;7(1):65-78.
  30. Gaurav N, Kumar A, Tyagi M, Kumar D, Chauhan UK, Singh AP. Morphology of Withania somnifera (distribution, morphology, phytosociology of Withania somnifera L. Dunal). Int J Current Sci Res. 2015;1(7):164-73.
  31. He J, ChenL, SiY, Huang B, BanX, Wang Y. Population structure and genetic diversity distribution in wild and cultivated populations of the traditional Chinese medicinal plant Magnolia officinalis subsp. biloba (Magnoliaceae). Genetica. 2009 Mar;135(2):233-43.
  32. Lv L, Kong Q, Li Z, Zhang Y, Chen B, Lv L, Zhang Y. Honokiol provides cardioprotection from myocardial ischemia/reperfusion injury (MI/RI) by inhibiting mitochondrial apoptosis via the PI3K/AKT signaling pathway. Cardiovascular Therapeutics. 2022; 2022(1):1001692.
  33. Padayachee B, Baijnath H. An overview of the medicinal importance of Moringaceae. J Med Plants Res. 2012 Dec 17;6(48):5831-9.
  34. Emongor VE. Moringa (Moringa oleifera Lam.): a review. InI All Africa Horticultural Congress 911 2009 Aug 31 (pp. 497-508).
  35. Alam K, Hoq O, Uddin S. Medicinal plant Allium sativum. A review. Journal of Medicinal Plants Studies. 2016 Oct;4(6):72-9.
  36. Norman J. Herb and Spices The Cook's Reference: Over 200 Herbs and Spices, with Recipes for Marinades, Spice Rubs, Oils and more. Dorling Kindersley Ltd; 2015 May1.
  37. Kains MG. Ginseng: its cultivation, harvesting, marketing and market value, with a short account of its history and botany. Orange Judd Company; 1903.
  38. Zhang ZB, Yu CY, Wang HY, Jia XB, Wu W, Pang ST, Li W, Zahoor S, Khan W, Liu YC, Yang B. The history, beneficial ingredients, mechanism, processing, and productsof Panax ginseng for medicinal and edible value. Food & Medicine Homology. 2025;2:9420059.
  39. Kim JH. Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. Journal of ginseng research. 2018 Jul 1;42(3):264-9.
  40. Jahanger M A, Patra K K, Kumari S, Singh A, Manika N, Srivastava R P, Saxena G, Singh L. A glance at the phytochemical and ethno-pharmacological understanding of four Ocimum species. Current Pharmaceutical Biotechnology. 2023 Jul 1;24(9):1094-107.
  41. Bhamra S K, Heinrich M, Johnson M R, Howard C, Slater A. The cultural and commercial value of Tulsi (Ocimum tenuiflorum L.): Multidisciplinary approaches focusing on species authentication. Plants. 2022 Nov 18;11(22):3160.
  42. Mohanty I, Arya DS, Gupta SK. Effect of Curcuma longa and Ocimum sanctum on myocardial apoptosis in experimentally induced myocardial ischemic-reperfusion injury. BMC complementary and alternative medicine. 2006 Feb 19;6(1):3.

Reference

  1. Zhang MX, Song Y, Xu WL, Zhang LX, Li C, Li YL. Natural herbal medicine as a treatment strategy for myocardial infarction through the regulation of angiogenesis. Evidence-Based Complementary and Alternative Medicine. 2022;2022(1):8831750
  2. Fathima SN. An update on myocardial infarction. Current Research and Trends in Medical Science and Technology. 2021;1:95.
  3. Oliveira GB, Avezum A, Roever L. Cardiovascular disease burden: evolving knowledge of risk factors in myocardial infarction and stroke through population-based research and perspectives in global prevention. Frontiers in cardiovascular medicine. 2015 Aug 13;2:32.
  4. Satish S, Aravind BC. Advancements In Pharmacotherapy for Myocardial Infarction: A Comprehensive Review.
  5. Frangogiannis NG. Pathophysiology of myocardial infarction. Comprehensive Physiology. 2015 Oct 17;5(4):1841-75
  6. Tibaut M, Mekis D, Petrovic D. Pathophysiology of myocardial infarction and acute management strategies. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Cardiovascular & Hematological Agents). 2016 Dec 1;14(3):150-9.
  7. Rosendorff C, Lackland D T, Allison M, Aronow W S, Black H R, Blumenthal R S, Cannon CP, De Lemos JA, Elliott WJ, Findeiss L, Gersh BJ. Treatment of hypertension inpatients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Journal of the American College of Cardiology. 2015 May 12;65(18):1998-2038.
  8. Hart BL. The evolution of herbal medicine: behavioural perspectives. Animal Behaviour. 2005 Nov 1;70(5):975-89.
  9. Shaito A, Thuan DT, Phu HT, Nguyen TH, Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH, Pintus G. Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety. Frontiers in pharmacology. 2020 Apr 7;11:422.
  10. Nisar A, Jagtap S, Vyavahare S, Deshpande M, Harsulkar A, Ranjekar P, Prakash O. Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinicaltrials to clinicalpractice. Frontiers in pharmacology. 2023 May9;14:1177050.
  11. Demirsoy E, Thielmann M. Abstracts from the 72nd Congress of the ESCVS, the European Society of CardioVascular and Endovascular Surgery. InMedical Sciences Forum 2025 Apr 3 (Vol. 31, No. 1, p. 1). MDPI.
  12. Veveris M, Koch E, Chatterjee SS. Crataegus special extract WS® 1442 improvescardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sciences. 2004 Feb 27;74(15):1945-55.
  13. Jain S, Yadav PP, Gill V, Vasudeva N, Singla N. Terminalia arjuna a sacred medicinal plant: phytochemical and pharmacological profile. Phytochemistry Reviews. 2009 Jun;8(2):491-502.
  14. Elsawy H, Almalki M, Elmenshawy O, Abdel-Moneim A. In vivo evaluation of the protective effects of arjunolic acid against lipopolysaccharide-induced septic myocardial injury. PeerJ. 2022 Feb 16;10:e12986.
  15. Srimachai S, Devaux S, Demougeot C, Kumphune S, Ullrich ND, Niggli E, Ingkaninan K, Kamkaew N, Scholfield CN, Tapechum S, Chootip K. Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury. BMC complementary and alternative medicine. 2017 Feb 20;17(1):117.
  16. Nandave M, Ojha SK, Joshi S, Kumari S, Arya D S. Moringa oleifera leaf extract prevents isoproterenol-induced myocardial damage in rats: evidence for an antioxidant, antiperoxidative, and cardioprotective intervention. Journal of medicinal food. 2009 Feb 1;12(1):47-55.
  17. Nyepetsi NG. Effects of dietary garcinia kola supplementation on inflammation and oxidative stress in isolated perfused rat hearts.
  18. Suleiman KY, Ajani EO, Biobaku KT, Okediran BS, Azeez MO, Jimoh GA, Aremu A, Ahmed AO. Cardioprotective effects of aqueous extract of ripped musa paradisiaca peelin isoproterenol induced myocardial infarction rat model. Biomedical Research and Therapy. 2021 Oct 29;8(10):4634-48.
  19. G Narayanan GN, K Prabhu KP, Bandhu Chaudhury A. Cardioprotective role of partharishtam on isopreterenol induced myocardial infarction in animal model.
  20. Mohamed D, Mabrok H, Abdelgayed S, Elbakry H. Cardioprotective potency of anthocyanin-rich extract of red cabbage against isoproterenol-induced myocardial infarction in experimental animals. Journal of Applied Pharmaceutical Science. 2021 Jun 12;11(8):022-30.
  21. Garg SS, Gupta J, Sahu D, Liu CJ. Pharmacological and therapeutic applications of esculetin. International journal of molecular sciences. 2022 Oct 20;23(20):12643.
  22. Hammoudeh AJ, Alhaddad IA. Triggers and the onset of acute myocardial infarction. Cardiology in Review. 2009 Nov 1;17(6):270-4.
  23. M?ynarska E, Czarnik W, Fularski P, Hajdys J, Majchrowicz G, Stabrawa M, Rysz J, Franczyk B. From atherosclerotic plaque to myocardial infarction—The leading cause of coronary artery occlusion. International journal of molecular sciences. 2024 Jul 2;25(13):7295.
  24. Nayler WG. Atherosclerosis and endothelial damage: a brief overview. Cardiovascular drugs and therapy. 1995 Jan;9(Suppl 1):25-30.
  25. Tiwari BS, Belenghi B, Levine A. Oxidative stress increased respiration and generationof reactive oxygen species, resulting in ATP depletion, opening of mitochondrial permeability transition, and programmed cell death. Plant physiology. 2002 Apr 1;128(4):1271-81.
  26. Perrelli MG, Pagliaro P, Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World journal of cardiology. 2011 Jun 26;3(6):186.
  27. Turner NA. Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). Journal of molecular and cellular cardiology. 2016;94:189-200.
  28. Stožer A, Vodopivc P, Bombek L K. Pathophysiology of exercise-induced muscle damage and its structural, functional, metabolic, and clinical consequences. Physiological research. 2020 Jul 16;69(4):565.
  29. Amalraj A, Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: a review. Journal of traditional and complementary medicine. 2017 Jan 1;7(1):65-78.
  30. Gaurav N, Kumar A, Tyagi M, Kumar D, Chauhan UK, Singh AP. Morphology of Withania somnifera (distribution, morphology, phytosociology of Withania somnifera L. Dunal). Int J Current Sci Res. 2015;1(7):164-73.
  31. He J, ChenL, SiY, Huang B, BanX, Wang Y. Population structure and genetic diversity distribution in wild and cultivated populations of the traditional Chinese medicinal plant Magnolia officinalis subsp. biloba (Magnoliaceae). Genetica. 2009 Mar;135(2):233-43.
  32. Lv L, Kong Q, Li Z, Zhang Y, Chen B, Lv L, Zhang Y. Honokiol provides cardioprotection from myocardial ischemia/reperfusion injury (MI/RI) by inhibiting mitochondrial apoptosis via the PI3K/AKT signaling pathway. Cardiovascular Therapeutics. 2022; 2022(1):1001692.
  33. Padayachee B, Baijnath H. An overview of the medicinal importance of Moringaceae. J Med Plants Res. 2012 Dec 17;6(48):5831-9.
  34. Emongor VE. Moringa (Moringa oleifera Lam.): a review. InI All Africa Horticultural Congress 911 2009 Aug 31 (pp. 497-508).
  35. Alam K, Hoq O, Uddin S. Medicinal plant Allium sativum. A review. Journal of Medicinal Plants Studies. 2016 Oct;4(6):72-9.
  36. Norman J. Herb and Spices The Cook's Reference: Over 200 Herbs and Spices, with Recipes for Marinades, Spice Rubs, Oils and more. Dorling Kindersley Ltd; 2015 May1.
  37. Kains MG. Ginseng: its cultivation, harvesting, marketing and market value, with a short account of its history and botany. Orange Judd Company; 1903.
  38. Zhang ZB, Yu CY, Wang HY, Jia XB, Wu W, Pang ST, Li W, Zahoor S, Khan W, Liu YC, Yang B. The history, beneficial ingredients, mechanism, processing, and productsof Panax ginseng for medicinal and edible value. Food & Medicine Homology. 2025;2:9420059.
  39. Kim JH. Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. Journal of ginseng research. 2018 Jul 1;42(3):264-9.
  40. Jahanger M A, Patra K K, Kumari S, Singh A, Manika N, Srivastava R P, Saxena G, Singh L. A glance at the phytochemical and ethno-pharmacological understanding of four Ocimum species. Current Pharmaceutical Biotechnology. 2023 Jul 1;24(9):1094-107.
  41. Bhamra S K, Heinrich M, Johnson M R, Howard C, Slater A. The cultural and commercial value of Tulsi (Ocimum tenuiflorum L.): Multidisciplinary approaches focusing on species authentication. Plants. 2022 Nov 18;11(22):3160.
  42. Mohanty I, Arya DS, Gupta SK. Effect of Curcuma longa and Ocimum sanctum on myocardial apoptosis in experimentally induced myocardial ischemic-reperfusion injury. BMC complementary and alternative medicine. 2006 Feb 19;6(1):3.

Photo
Takeshwar
Corresponding author

Department of Pharmacy, LCIT School of Pharmacy, Bilaspur

Photo
Md Akib Quraishi
Co-author

Department of Pharmacy, LCIT School of Pharmacy, Bilaspur

Takeshwar, Md Akib Quraishi, Herbal Approaches in the Treatment of Myocardial Infarction : A Phytochemical Perspective, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 3, 3677-3690. https://doi.org/10.5281/zenodo.19257045

More related articles
Pharmacological Evaluation of Nyctanthes arbor-tri...
Renu Lata, Megha Mittal, Dr. Aakash Jain, Dr. Jasmine Jain, Dr. H...
Formulation and Evaluation of Hand Sanitizer using...
Tejal Bute, Kalyani Sadafale, Aditya Unhale, Dr. Swati Deshmukh, ...
Identify And Evaluate The Phytochemical Properties Of Ashoka Bark In Fibroids...
Suraj Dewangan, Victor Lal, Vasundhara Jaiswal, Shruti Rathore, Divyani Soni, ...
Tridax procumbens (L.): A Comprehensive Pharmacological and Therapeutic Review o...
Vishal Pawar, Savita Bhise, Gaurav Ghadge, Adarsh Malave, Sayali Mane, ...
Design, Formulation & Characterisation of An Effective Anti-Fungal & Anti-Microb...
Ajay Suryawanshi, Purnima Baghel, Sweety Lanjhiyana, ...
Related Articles
Formulation And Evaluation of SNEDDS-Based Moisturising Cream Loaded with Serum ...
Fathima Shajahan , Anju V. S., Lekshmi M. S. Panicker, Steeve Shibbu Daniel, Akshara J. M., ...
Rosemantra: The Unique Herbal Cold Cream...
Prajakta Vidhate, Bhakti Shirke, Aamena Simeem, Smita Kirtikar, S. S. Kulkarni, ...
Formulation And Evaluation Of Polyherbal Hair Oil...
Namita Sagvekar, , Aishwarya Kocharekar, Gauri Patki, Swapnali Gawas, ...
Pharmacological Evaluation of Nyctanthes arbor-tristis...
Renu Lata, Megha Mittal, Dr. Aakash Jain, Dr. Jasmine Jain, Dr. Hema Choudhry, Dr. Parveen Parihar, ...
More related articles
Pharmacological Evaluation of Nyctanthes arbor-tristis...
Renu Lata, Megha Mittal, Dr. Aakash Jain, Dr. Jasmine Jain, Dr. Hema Choudhry, Dr. Parveen Parihar, ...
Formulation and Evaluation of Hand Sanitizer using Neem and Turmeric Extract ...
Tejal Bute, Kalyani Sadafale, Aditya Unhale, Dr. Swati Deshmukh, ...
Pharmacological Evaluation of Nyctanthes arbor-tristis...
Renu Lata, Megha Mittal, Dr. Aakash Jain, Dr. Jasmine Jain, Dr. Hema Choudhry, Dr. Parveen Parihar, ...
Formulation and Evaluation of Hand Sanitizer using Neem and Turmeric Extract ...
Tejal Bute, Kalyani Sadafale, Aditya Unhale, Dr. Swati Deshmukh, ...